Physician

Satyavardhan Pulukurthy, MD

According to 2025 Medicare claims, Satyavardhan Pulukurthy, MD (NPI: 1902838154) practices interventional cardiology in the Bremerton-Silverdale-Port Orchard, WA market, with the plurality of this provider's patient population coming from Kitsap, WA. This provider's primary affiliated billing organization is FRANCISCAN MEDICAL GROUP (NPI: 1366539421; TIN: 911939739) and primary practice location at 98383-7663. Pulukurthy is affiliated with the CommonSpirit ACO I (ACO ID: A2164) and Jefferson Accountable Care, LLC (ACO ID: A5275), participating under the MSSP model.

Pulukurthy's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,635 traditional Medicare patients, billed 9,129 HCPCS/CPT codes, and received $523,740 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 5,955 prescription claims across 855 beneficiaries totaling $2,176,747 in drug costs, led by Vyndamax (Tafamidis). 2023 DME data shows 24 claims. Open Payments data shows 46 records totaling $3,650. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $207,374 to $2,176,747. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,887	8,348	$605,672
2016	2,712	7,736	$504,362
2017	2,975	8,969	$571,170
2018	2,977	8,471	$583,580
2019	2,840	8,471	$584,610
2020	2,624	8,014	$542,623
2021	2,582	8,272	$577,439
2022	2,671	8,677	$515,787
2023	2,469	7,643	$430,532
2024	2,635	9,129	$523,740

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	394	2,673	$207,374
2016	403	2,850	$216,731
2017	409	2,877	$241,656
2018	436	2,789	$276,675
2019	475	3,303	$407,922
2020	563	4,218	$667,428
2021	642	4,547	$818,395
2022	670	4,828	$975,286
2023	722	5,034	$1,436,661
2024	855	5,955	$2,176,747

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	24	$2,188
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	24	$1,823
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	568	602	$88
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	601	607	$88
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	350	360	$10
99152	Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes	454	510	$9
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	779	1,089	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Vyndamax	Tafamidis	23	690	$529,503
Eliquis	Apixaban	306	21,357	$410,709
Jardiance	Empagliflozin	279	20,297	$368,750
Entresto	Sacubitril/Valsartan	186	12,276	$266,331
Xarelto	Rivaroxaban	155	12,298	$222,831

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	46	$3,650	Medtronic, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Satyavardhan Pulukurthy, MD?

Tedicare shows public-source Medicare data for Satyavardhan Pulukurthy, MD (NPI 1902838154), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Satyavardhan Pulukurthy, MD have ACO affiliation data?

Satyavardhan Pulukurthy, MD is shown with ACO affiliation data for CommonSpirit ACO I (MSSP, ACO ID A2164) and Jefferson Accountable Care, LLC (MSSP, ACO ID A5275).

What billing organization is linked to Satyavardhan Pulukurthy, MD?

Satyavardhan Pulukurthy, MD is linked to FRANCISCAN MEDICAL GROUP (billing NPI 1366539421) in the available physician profile data.

Does Satyavardhan Pulukurthy, MD have Open Payments data?

Satyavardhan Pulukurthy, MD has 46 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.